Dr. Daver on CAR T-Cell Therapy Approval in Pediatric ALL
November 16th 2017Naval Daver, MD, assistant professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the approval of a chimeric antigen receptor (CAR) T-cell therapy in pediatric acute lymphoblastic leukemia.
Read More
Dr. Daver on Immune Checkpoint Pathways in AML
December 28th 2016Naval Daver, MD, assistant professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses research evaluating different immune checkpoint pathways in patients with acute myeloid leukemia.
Read More
Dr Marth on Frontline Lenvatinib Plus Pembrolizumab in Endometrial Cancer
Dr Mirza on the Findings From Part 2 of the RUBY Trial in Endometrial Cancer
Mahtani Emphasizes Empowering Women in Oncology Through Sponsorship, Support Networks, and Self Care
McCann on the Intersection of Mentorship, Multidisciplinary Care, and Career Aspirations as a Woman in Oncology
2 Commerce Drive
Cranbury, NJ 08512